Natco Pharma Ltd.

View in App
848.80 -0.70 ▼-0.1%

25 September 2023, 04:01:00 PM
Volume: 21,577

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.natcopharma.co.in
Market Cap 15,202.85 Cr.
Enterprise Value(EV) 14,821.55 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 45.51 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 18.65 Trailing Twelve Months Ending 2023-06
Industry PE 37.43 Trailing Twelve Months Ending 2023-06
Book Value / Share 284.15 Trailing Twelve Months Ending 2023-06
Price to Book Value 2.99 Calculated using Price: 848.80
Dividend Yield 0.65 Period Ending 2023-03
No. of Shares Subscribed 17.91 Cr. 179,109,870 Shares
FaceValue 2
About Natco Pharma Ltd.
Natco Pharma is a vertically integrated and R&D focused pharmaceutical company engaged in developing, manufacturing and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). It is also engaged in contract manufacturing business, whereby it undertake selected contracts with pharmaceutical companies to manufacture and supply pharmaceutical products. It has diversified into the business of crop health sciences to leverage is skills in organic chemistry.

Natco Pharma Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Natco Pharma Ltd. Performance

View details >>
1 Day
-0.08%
1 Week
-4.08%
1 Month
-3.20%
3 Month
+35.39%
6 Month
+54.57%
1 Year
+33.64%
2 Year
-5.07%
5 Year
+7.70%
10 Year
+585.51%

Natco Pharma Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 15.90 14.41 33.21 29.70 19.75 12.71 11.27 4.06 15.66
Return on Capital Employed (%) 14.89 17.49 39.21 35.28 23.71 14.82 13.99 4.86 18.06
Return on Assets (%) 9.69 9.58 23.43 23.05 16.02 10.30 9.43 3.43 13.29

Natco Pharma Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 726 846 1,296 1,649 3,072 3,489 3,774 4,122 4,264 4,874
Non Curr. Liab. 151 119 28 38 47 83 118 143 135 101
Curr. Liab. 312 414 493 627 592 729 685 526 710 683
Minority Int. 7 5 5 4 4 2 11 2
Equity & Liab. 1,196 1,384 1,822 2,318 3,715 4,303 4,588 4,792 5,109 5,657
Non Curr. Assets 828 901 985 1,230 1,584 1,956 2,262 2,447 2,622 2,657
Curr. Assets 368 483 837 1,087 2,131 2,347 2,326 2,345 2,487 3,000
Misc. Exp. not W/O
Total Assets 1,196 1,384 1,822 2,318 3,715 4,303 4,588 4,792 5,109 5,657

Natco Pharma Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 825 1,042 2,020 2,185 2,095 1,915 2,052 1,945 2,707 2,963
Other Income 15 10 14 40 130 107 106 99 129 90
Total Income 840 1,052 2,034 2,225 2,225 2,022 2,158 2,044 2,836 3,053
Total Expenditure -620 -777 -1,337 -1,256 -1,300 -1,332 -1,448 -1,681 -1,795 -1,895
PBIDT 221 275 697 969 925 690 710 363 1,040 1,158
Interest -32 -23 -19 -15 -19 -22 -13 -18 -15 -15
Depreciation -47 -51 -54 -66 -81 -100 -117 -143 -164 -168
Taxation -2 -48 -140 -192 -182 -111 -137 -32 -147 -161
Exceptional Items -15
PAT 125 154 485 695 642 458 442 170 715 815
Minority Interest 4 1 1 1 2 3 -2
Share Associate
Other Related Items
Consolidated Net Profit 135 157 486 696 644 461 441 170 715 815
Adjusted EPS 8 9 28 38 35 25 24 9 39 45

Natco Pharma Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 144 93 112 346 464 669 417 299 47 849
Cash Fr. Inv. -109 -115 -176 -299 -1,116 -612 -167 -103 -5 -477
Cash Fr. Finan. -35 29 154 -48 651 -51 -251 -186 35 -363
Net Change 0 7 91 -1 -1 6 -1 10 76 9
Cash & Cash Eqvt 10 12 -74 24 22 28 20 26 111 132

Natco Pharma Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 48.87 48.87 48.86 48.81 48.80 48.80 48.82 48.84 49.76
Public 51.13 51.13 51.14 51.19 51.20 51.20 51.18 51.16 50.24
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Natco Pharma Ltd. Announcements

View details >>
Thu, 21 Sep 2023
Book Closure
Book Closure for 40th Annual General Meeting
Fri, 08 Sep 2023
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Legal Update
Thu, 07 Sep 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of Letter of confirmation of duplicate share certificate

Natco Pharma Ltd. Technical Scans

View details >>
Mon, 25 Sep 2023
Opening at Low Opening at Low
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Within 52 Week High Zone Close Within 52 Week High Zone
Making Lower Lows for 2 Days Making Lower Lows for 2 Days
High Increase in 3 Months High Increase in 3 Months

Natco Pharma Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 269,697.25 1,124.05 -0.7%
Divi's Laboratories Ltd. 99,021.11 3,730.05 +0.6%
Cipla Ltd. 95,166.58 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. 90,720.90 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. 73,268.35 5,095.45 +2.2%
Mankind Pharma Ltd. 69,694.38 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. 62,519.33 1,844.85 -0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 31.97 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-06 67.03 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-06 30.62 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.21 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 109.58 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 54.37 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 49.55 1,844.85 -0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.65 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-06 7.55 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-06 3.91 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.70 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.68 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 5.69 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.49 1,844.85 -0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-03 0.02 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,844.85 -0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,844.85 -0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,844.85 -0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,844.85 -0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,844.85 -0.3%

Natco Pharma Ltd. FAQ's

What is Natco Pharma share price?
Can I buy Natco Pharma shares now?
What is the Dividend Yield of Natco Pharma?
What is the Market Cap of Natco Pharma?
What are the key metrics to analyse Natco Pharma?
What is the 52 Week High and Low of Natco Pharma?
What is the trend of Natco Pharma share price?